Cargando…
Desmopressin use prior to renal transplant biopsy—does it fit?
Desmopressin acetate (DDAVP), a selective agonist of type 2 vasopressin receptors, is sometimes used prior to percutaneous renal biopsy to reduce the risk of bleeding complications. DDAVP increases free water reabsorption in renal collecting ducts, potentially leading to water intoxication or diluti...
Autores principales: | Anandagoda, Nelomi, Jayawardene, Satish, Macdougall, Iain C., Shah, Sapna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389145/ https://www.ncbi.nlm.nih.gov/pubmed/25859381 http://dx.doi.org/10.1093/ckj/sfu110 |
Ejemplares similares
-
Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk
por: Leclerc, Simon, et al.
Publicado: (2020) -
Safety of renal biopsy bleeding prophylaxis with desmopressin
por: Barrios, R. Haridian Sosa, et al.
Publicado: (2021) -
Much more than gastro-enteritis: a severe case of hypo-pituitarism
por: Vandermolen, Sebastian, et al.
Publicado: (2014) -
AA Amyloidosis in a patient with glycogen storage disorder and progressive chronic kidney disease
por: Dick, Jonathan, et al.
Publicado: (2012) -
Case Report: Hyponatremia Secondary to Desmopressin Administration Prior to Percutaneous Kidney Biopsy: A Case-Based Review
por: Vornicu, Alexandra, et al.
Publicado: (2021)